bpMedManage: Digital Technology to Support Adherence to Hypertension Medications
The purpose of the bpMedManage study is to rigorously test the efficacy of a smartphone technology to help improve high blood pressure medication adherence among older adults with mild cognitive impairment (MCI) in a 16-week randomized controlled trial. A total of 100 older adults will be recruited. There will be two t
| Condition(s) | Aging, Mild Cognitive Impairment, Hypertension |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | The purpose of the bpMedManage study is to rigorously test the efficacy of a smartphone technology to help improve high blood pressure medication adherence among older adults with mild cognitive impairment (MCI) in a 16-week randomized controlled trial. A total of 100 older adults will be recruited. There will be two treatment arms, bpMedManage-S and bpMedManage-P with 50 participants in each arm. Participants randomized into the bpMEDManage-S intervention arm will use a smartphone application with medication reminders plus receive education with standardized information on hypertension and antihypertensive medications on the education portal. Participants in the bpMedManage-P group will use a smartphone to receive education with standardized information on hypertension and antihypertensiv |
| Who can participate | Inclusion Criteria: 1. Age 60+ 2. Community-dwelling older adults 3. Self-reported fluent in English 4. Adequate self-reported visual and hearing ability 5. Self-reported memory, thinking, or concentration challenges 6. Self-manage at least one prescribed antihypertensive medication 7. Have and use a smartphone 8. No self-reported history of major depression or other mental health diagnoses 9. No self-reported diagnosis of dementia or other neurological disorder such as stroke, TBI, and Parkinson's disease 10. TICS-M score between 27-37 and Montreal Cognitive Assessment (MoCA) score between 20-26 11. Willing to participate in the study for at least 4 months Exclusion Criteria: 1. Diagnosis of dementia 2. Lives in assisted living facility or skilled nursing facility |
| Ages | 60 Years |
| Sex | All |
| Lead sponsor | University of Arizona |
| Locations | Tucson, Arizona, United States; Champaign, Illinois, United States |
| Start date | 2024-02-29 |
| NCT ID | NCT06307574 |
| Official listing | https://clinicaltrials.gov/study/NCT06307574 |